Literature DB >> 3191509

Structural studies on oncofetal carbohydrate antigens (Ca 19-9, Ca 50, and Ca 125) carried by O-linked sialyloligosaccharides on human amniotic mucins.

F G Hanisch1, G Uhlenbruck, J Peter-Katalinic, H Egge.   

Abstract

Mucins were extracted from human amniotic fluid in the presence of 45% vol. phenol and separated from the bulk of smaller-sized glycoproteins by exclusion on Sephacryl S400. The mucin-fraction FW, which still contained a minute proportion of mannose, strongly expressed oncofetal antigens recognized by monoclonal antibodies C 50, NS 19-9, OC 125, Leu M1, 49 H 8, and 115 C 2. The structures of the respective mucin-linked saccharides responsible for Ca 50-, Ca 19-9-, and Lea-related antigenic activities were analyzed before or after reductive beta-elimination from sialylglycoproteins, and purification of the derived alditols by gel-permeation chromatography on Bio-Gel P-4 or high performance liquid chromatography. Two ubiquitous (FW2, FW3) and three novel oligosaccharide alditols (FW5) were characterized by f.a.b.- and e.i.-m.s., combined with methylation analysis and chromium trioxide oxidation. The OC 125 epitope on mucin-carried O-glycans was destroyed during reductive cleavage of the saccharides, indicating a conformational involvement of the reducing terminal residue and its mode of conjugation to the protein. Exoglycosidase treatment of the mucin-bound antigen revealed that the epitope structure of OC 125 includes terminal beta-D-galactosyl groups, and terminal sialyl groups that are almost inaccessible to Vibrio cholerae sialidase digestion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3191509     DOI: 10.1016/0008-6215(88)80100-9

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  6 in total

1.  Structural studies of gangliosides from the YAC-1 mouse lymphoma cell line by immunological detection and fast atom bombardment mass spectrometry.

Authors:  J Müthing; J Peter-Katalinić; F G Hanisch; U Neumann
Journal:  Glycoconj J       Date:  1991-10       Impact factor: 2.916

Review 2.  The trail of my studies on glycoproteins from enterokinase to tumor markers.

Authors:  Ikuo Yamashina
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

Review 3.  Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics.

Authors:  Alan Kirwan; Marta Utratna; Michael E O'Dwyer; Lokesh Joshi; Michelle Kilcoyne
Journal:  Biomed Res Int       Date:  2015-10-05       Impact factor: 3.411

Review 4.  MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.

Authors:  Mildred Felder; Arvinder Kapur; Jesus Gonzalez-Bosquet; Sachi Horibata; Joseph Heintz; Ralph Albrecht; Lucas Fass; Justanjyot Kaur; Kevin Hu; Hadi Shojaei; Rebecca J Whelan; Manish S Patankar
Journal:  Mol Cancer       Date:  2014-05-29       Impact factor: 27.401

5.  Human Natural Antibodies Recognizing Glycan Galβ1-3GlcNAc (LeC).

Authors:  Kira Dobrochaeva; Nailya Khasbiullina; Nadezhda Shilova; Nadezhda Antipova; Polina Obukhova; Oxana Galanina; Mikhail Gorbach; Inna Popova; Sergey Khaidukov; Natalia Grishchenko; Nikolai Tupitsyn; Jacques Le Pendu; Nicolai Bovin
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

6.  PDX-derived organoids model in vivo drug response and secrete biomarkers.

Authors:  Ling Huang; Bruno Bockorny; Indranil Paul; Dipikaa Akshinthala; Pierre-Oliver Frappart; Omar Gandarilla; Arindam Bose; Veronica Sanchez-Gonzalez; Emily E Rouse; Sylvain D Lehoux; Nicole Pandell; Christine M Lim; John G Clohessy; Joseph Grossman; Raul Gonzalez; Sofia Perea Del Pino; George Daaboul; Mandeep S Sawhney; Steven D Freedman; Alexander Kleger; Richard D Cummings; Andrew Emili; Lakshmi B Muthuswamy; Manuel Hidalgo; Senthil K Muthuswamy
Journal:  JCI Insight       Date:  2020-11-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.